HIF1A and hepatocellular carcinoma: KN-62, a pharmacological inhibitor of CaMK2, specifically and effectively suppressed protein synthesis and the functional activity of hypoxia-inducible factor (HIF)-1α in hepatoma cells during hypoxia.